Miracor Medical Systems announced today that clinical data involving a study of its PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) System will be presented from the podium next week at “EuroPCR.” PICSO is designed to improve myocardial perfusion following primary PCI (percutaneous coronary intervention, or angioplasty).
Help employers find you! Check out all the jobs and post your resume.
